These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 27225440

  • 1. Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.
    Valencia SH, Ocampo ID, Arce-Plata MI, Recht J, Arévalo-Herrera M.
    Malar J; 2016 May 26; 15(1):291. PubMed ID: 27225440
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prevalence of G6PD deficiency and submicroscopic malaria parasites carriage in malaria hotspot area in Northwest, Tanzania.
    Manjurano A, Lyimo E, Kishamawe C, Omolo J, Mosha J, Donald M, Kazyoba P, Kapiga S, Changalucha J.
    Malar J; 2023 Dec 07; 22(1):372. PubMed ID: 38062464
    [Abstract] [Full Text] [Related]

  • 4. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.
    Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, Hogg MM, Battle KE, Padilla CD, Baird JK, Hay SI.
    PLoS Med; 2012 Dec 07; 9(11):e1001339. PubMed ID: 23152723
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030.
    Ong KIC, Iwagami M, Araki H, Khattignavong P, Soundala P, Keomalaphet S, Prasayasith P, Lorpachan L, Xangsayalath P, Pongvongsa T, Hongvanthong B, Brey PT, Kano S, Jimba M.
    Malar J; 2019 Mar 12; 18(1):75. PubMed ID: 30866940
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prevalence of Glucose 6-Phosphate Dehydrogenase Variants in Malaria-Endemic Areas of South Central Timor, Eastern Indonesia.
    Sulistyaningrum N, Arlinda D, Hutagalung J, Sunarno S, Oktoberia IS, Handayani S, Ekowatiningsih R, Yusnita EA, Prasetyorini B, Rizki A, Tjitra E, Na-Bangchang K, Chaijaroenkul W.
    Am J Trop Med Hyg; 2020 Aug 12; 103(2):760-766. PubMed ID: 32602432
    [Abstract] [Full Text] [Related]

  • 9. Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa.
    Awandu SS, Raman J, Makhanthisa TI, Kruger P, Frean J, Bousema T, Niemand J, Birkholtz LM.
    Malar J; 2018 Mar 20; 17(1):120. PubMed ID: 29558929
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prevalence and distribution of glucose-6-phosphate dehydrogenase (G6PD) variants in Thai and Burmese populations in malaria endemic areas of Thailand.
    Phompradit P, Kuesap J, Chaijaroenkul W, Rueangweerayut R, Hongkaew Y, Yamnuan R, Na-Bangchang K.
    Malar J; 2011 Dec 15; 10():368. PubMed ID: 22171972
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Glucose-6-phosphate dehydrogenase deficiency in people living in malaria endemic districts of Nepal.
    Ghimire P, Singh N, Ortega L, Rijal KR, Adhikari B, Thakur GD, Marasini B.
    Malar J; 2017 May 23; 16(1):214. PubMed ID: 28535765
    [Abstract] [Full Text] [Related]

  • 16. G6PD deficiency in Latin America: systematic review on prevalence and variants.
    Monteiro WM, Val FF, Siqueira AM, Franca GP, Sampaio VS, Melo GC, Almeida AC, Brito MA, Peixoto HM, Fuller D, Bassat Q, Romero GA, Maria Regina F O, Marcus Vinícius G L.
    Mem Inst Oswaldo Cruz; 2014 Aug 23; 109(5):553-68. PubMed ID: 25141282
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients.
    Avalos S, Mejia RE, Banegas E, Salinas C, Gutierrez L, Fajardo M, Galo S, Pinto A, Mejia A, Fontecha G.
    Malar J; 2018 Nov 08; 17(1):415. PubMed ID: 30409136
    [Abstract] [Full Text] [Related]

  • 19. Linked-evidence modelling of qualitative G6PD testing to inform low- and intermediate-dose primaquine treatment for radical cure of Plasmodium vivax.
    Gatton ML.
    PLoS Negl Trop Dis; 2024 Sep 08; 18(9):e0012486. PubMed ID: 39236082
    [Abstract] [Full Text] [Related]

  • 20. Low and heterogeneous prevalence of glucose-6-phosphate dehydrogenase deficiency in different settings in Ethiopia using phenotyping and genotyping approaches.
    Shitaye G, Gadisa E, Grignard L, Shumie G, Chali W, Menberu T, Belachew M, Tegegn G, Challi S, Curry J, Mahey L, Hailu T, Mamo H, Menon M, Balcha T, Aseffa A, Drakeley C, Bousema T, Tadesse FG.
    Malar J; 2018 Aug 02; 17(1):281. PubMed ID: 30071859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.